These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 29946941

  • 1. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.
    Lee BC, Liu KL, Wu CH, Huang KW, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH, Liang PC.
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1699-1707. PubMed ID: 29946941
    [Abstract] [Full Text] [Related]

  • 2. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D, Cho SK, Shin SW, Rhim H, Koh KC, Paik SW.
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [Abstract] [Full Text] [Related]

  • 4. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS, Do YS.
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, Yamamoto H.
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [Abstract] [Full Text] [Related]

  • 6. Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria.
    Liu PH, Lee YH, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI.
    Ann Surg Oncol; 2014 Nov; 21(12):3835-43. PubMed ID: 24903236
    [Abstract] [Full Text] [Related]

  • 7. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.
    Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
    [Abstract] [Full Text] [Related]

  • 8. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [Abstract] [Full Text] [Related]

  • 9. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW, Chen YS, Lo GH, Hsu YC, Hsu CC, Wu TC, Yeh JH, Hsiao P, Hsieh PM, Lin HY, Shu CW, Hung CM.
    BMC Gastroenterol; 2020 Apr 10; 20(1):99. PubMed ID: 32272898
    [Abstract] [Full Text] [Related]

  • 10. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.
    Kim SS, Kang TW, Kim M, Lee MW, Cho SK, Paik YH, Kim MJ.
    Clin Radiol; 2018 Feb 10; 73(2):216.e1-216.e8. PubMed ID: 28859852
    [Abstract] [Full Text] [Related]

  • 11. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M.
    Eur Radiol; 2018 Aug 10; 28(8):3522-3531. PubMed ID: 29536241
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q, Ren W, Fan L, Zhao M, Mao L, Jiang S, Zhao C, Cui Y.
    Dig Dis Sci; 2020 Apr 10; 65(4):1266-1275. PubMed ID: 31312995
    [Abstract] [Full Text] [Related]

  • 13. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry.
    Lee SH, Jin YJ, Lee JW.
    Medicine (Baltimore); 2017 Nov 10; 96(44):e8486. PubMed ID: 29095307
    [Abstract] [Full Text] [Related]

  • 14. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D, Cho SK, Shin SW, Park KB, Park HS, Choo SW, Do YS, Choo IW, Lee MW, Rhim H, Lim HK.
    Cardiovasc Intervent Radiol; 2016 Mar 10; 39(3):417-25. PubMed ID: 26246215
    [Abstract] [Full Text] [Related]

  • 15. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.
    Eur J Radiol; 2012 Mar 10; 81(3):e189-93. PubMed ID: 21353417
    [Abstract] [Full Text] [Related]

  • 16. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY.
    J Gastroenterol Hepatol; 2014 May 10; 29(5):1056-64. PubMed ID: 24372785
    [Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller.
    Kim JW, Kim JH, Sung KB, Ko HK, Shin JH, Kim PN, Choi HK, Ko GY, Yoon HK, Chun SY, Gwon DI.
    Am J Gastroenterol; 2014 Aug 10; 109(8):1234-40. PubMed ID: 24935276
    [Abstract] [Full Text] [Related]

  • 18. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH, Kim PN, Won HJ, Shin YM.
    AJR Am J Roentgenol; 2014 Nov 10; 203(5):1127-31. PubMed ID: 25341154
    [Abstract] [Full Text] [Related]

  • 19. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
    Zuo TY, Liu FY, Wang MQ, Chen XX.
    Chin Med J (Engl); 2017 Nov 20; 130(22):2666-2673. PubMed ID: 29133753
    [Abstract] [Full Text] [Related]

  • 20. Chemoembolization versus radiofrequency ablation for single small (≤ 3 cm) hepatocellular carcinoma: a propensity score matching analysis.
    Kim GH, Kim JH, Shim JH, Kim SY, Kim PH, Ko HK, Gwon DI, Shin JH, Lee SJ, Chu HH, Won HJ, Shin YM, Kim N.
    Eur Radiol; 2024 Sep 20; 34(9):5517-5528. PubMed ID: 38329504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.